GLP-1 agonists are medications that help lower blood sugar levels and promote weight loss. There are many different types. And they’re just one part of your treatment plan if you have Type 2 diabetes or obesity. Your healthcare provider can help you decide if they’re right for you. What are GLP-1 agonists?

Glucagon-like peptide-1 (GLP-1) is a 30- or 31-amino-acid-long peptide hormone deriving from tissue-specific posttranslational processing of the proglucagon peptide. It is produced and secreted by intestinal enteroendocrine L-cells and certain neurons within the nucleus of the solitary tract in the brainstem upon food consumption.

2025年2月14日 · GLP-1 agonist drugs treat diabetes by balancing blood glucose levels. Here’s our list of GLP-1 agonists, how they work, similarities and differences, and more.

2024年3月13日 · Foods high in protein, fiber, and healthy fats can trigger the release of GLP-1, an important hormone that helps regulate blood sugar levels and promotes a feeling of fullness. Glucagon-like...

Losing weight can often be challenging. The good news is a class of medications called GLP-1 (glucagon-like peptide 1) agonists are emerging as true game changers, helping to control appetite and hunger, and allowing some people to shed pounds they’ve struggled to …

2024年2月29日 · GLP-1 agonists (also known as GLP-1 receptor agonists, incretin mimetics, or GLP-1 analogs) represent a class of medications used to treat T2DM and, in some cases, obesity. Examples of drugs in this class include Exenatide, Liraglutide, Dulaglutide, and Semaglutide.

2024年7月26日 · GLP-1 is a natural hormone made in the gut that’s released after we eat. It stimulates the release of insulin, another hormone whose job it is to take glucose from the bloodstream and...

2025年2月11日 · Glucagon-like peptide-1 (GLP-1) is a natural gut hormone your body releases after eating. There are medications that mimic its effects, such as semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound). GLP-1 …

GLP-1 agonists work by activating the GLP-1 receptor. They slow gastric emptying, inhibit the release of glucagon, and stimulate insulin production, therefore reducing hyperglycemia in people with type 2 diabetes. They also reduce food intake and therefore body weight, making them an effective treatment for obesity. [2] .

2024年9月18日 · We introduce recent studies that demonstrate the remarkable performance of GLP-1RAs in slowing the progression of neurodegenerative diseases, reducing inflammation, and enhancing cardiovascular...